HUTCHMED (China) (HCM) Amortization of Deferred Charges (2020 - 2021)
HUTCHMED (China)'s (HCM) quarterly Amortization of Deferred Charges came in at -$1.9 million in Q1 2021, down 342.09% year-on-year from $765000.0 in Q1 2020, and down 342.09% on a QoQ basis from $765000.0 in Q1 2020.
HUTCHMED (China) (HCM) Amortization of Deferred Charges (2020 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 2 years of Amortization of Deferred Charges data on file, last reported at -$1.9 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 9.54 Bn | 9.37 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -1.85 Mn |
| Mar 31, 2021 | -1.85 Mn |
| Mar 31, 2020 | 765,000.00 |
| Mar 31, 2020 | 765,000.00 |